Literature DB >> 26385610

Outcomes and Return to Activity After Operative Repair of Chronic Latent Syndesmotic Instability.

Paul M Ryan1, Ryan M Rodriguez2.   

Abstract

BACKGROUND: This study is a retrospective review of prospectively gathered data determining the postoperative outcomes of patients who underwent operative treatment to address chronic syndesmotic instability.
METHODS: The cohort is composed of 19 individuals who elected to undergo operative treatment of chronic syndesmotic instability. The operative repair consisted of arthroscopic debridement in all cases with reduction and suture button fixation of those patients who had greater than 4 mm of syndesmotic diastasis on arthroscopic evaluation. All patients had a minimum of 24 months follow-up. This study retrospectively examined the prospectively gathered preoperative and postoperative outcome scores to include a Visual Analog Scale (VAS) pain score and an American Orthopaedic Foot & Ankle Society (AOFAS) ankle-hindfoot score. In addition, patients were questioned on their ability to return to their preinjury level of activity and their ability to continue running sports. Fourteen patients returned their postoperative surveys.
RESULTS: Mean AOFAS scores improved significantly from 48 to 82.7 (P = .014). Mean VAS scores improved from 6.1 to 1.0 (P = .002). Overall, 86% (12/14) of patients were able to return to running and 79% (11/14) of patients were able to return to their preinjury level of sport. Preoperative and postoperative weight-bearing ankle radiographs were reviewed to evaluate the tibiofibular clear space and overlap. The clear space measured on anteroposterior (AP) radiographs decreased from 5.4 mm to 4.6 mm (P = .005), the clear space evaluated on the mortise radiograph decreased from 4.5 mm to 3.6 mm (P = .006), and the overlap measured on the AP radiograph increased from 5.7 mm to 6.9 mm (P = .019). All radiographs were measured by a board-certified musculoskeletal radiologist.
CONCLUSION: This study presents a treatment method that can be instituted at the time of diagnosis for syndesmotic injuries with greater than 4 mm of diastasis that were treated with debridement and stabilization. The results of this treatment technique are promising, with significant improvements in subjective outcome scores and a high rate of return to running sports. LEVEL OF EVIDENCE: Level IV, retrospective case series.
© The Author(s) 2015.

Entities:  

Keywords:  arthritis; biomechanics; outcome studies; sports; trauma

Mesh:

Year:  2015        PMID: 26385610     DOI: 10.1177/1071100715606488

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  4 in total

Review 1.  Imaging in syndesmotic injury: a systematic literature review.

Authors:  Nicola Krähenbühl; Maxwell W Weinberg; Nathan P Davidson; Megan K Mills; Beat Hintermann; Charles L Saltzman; Alexej Barg
Journal:  Skeletal Radiol       Date:  2017-11-30       Impact factor: 2.199

2.  The arthroscopic syndesmotic assessment tool can differentiate between stable and unstable ankle syndesmoses.

Authors:  Bart Lubberts; Daniel Guss; Bryan G Vopat; Anne H Johnson; C Niek van Dijk; Hang Lee; Christopher W DiGiovanni
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-10-26       Impact factor: 4.342

3.  Arthroscopic coronal plane syndesmotic instability has been over-diagnosed.

Authors:  Noortje C Hagemeijer; Mohamed Abdelaziz Elghazy; Gregory Waryasz; Daniel Guss; Christopher W DiGiovanni; Gino M M J Kerkhoffs
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-05-25       Impact factor: 4.342

4.  APKASS Consensus Statement on Chronic Syndesmosis Injury, Part 1: Clinical Manifestation, Radiologic Examination, Diagnosis Criteria, Classification, and Nonoperative Treatment.

Authors:  Chen Jiao; Jianchao Gui; Hiroaki Kurokawa; Yasuhito Tanaka; Patrick Yung; Seung Hwan Han; Chayanin Angthong; Yujie Song; Yinghui Hua; Hongyun Li; Zhongmin Shi; Qi Li; Samuel K K Ling
Journal:  Orthop J Sports Med       Date:  2021-06-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.